MM-09 (Immunotek)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameMM-09 (Immunotek)
Drug Alias NameDermatophagoides farinae/Dermatophagoides pteronyssinus allergen immunotherapy-InmunotekHouse dust mite allery immunotherapy D. pteronyssinus/D. farinae-InmunotekMM-09MG-01MM09-MG01
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDrug HypersensitivityHypersensitivityConjunctivitis, Allergic +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugalArgentinaSpain +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesInmunotek Sl
China Registration ClassN/A

Develop Information

Active CompaniesShanghai HOB Biological Medicine Co LtdInmunotek Sl
Inactive CompaniesN/A
Active IndicationsDrug HypersensitivityHypersensitivityConjunctivitis, Allergic +[8] 
Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A